FDA Releases Draft Guidance on Mass Spectrometry for Animal Drug Residue Confirmation

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the principles for using mass spectrometry to confirm the identity of animal drug residues, aimed at technical professionals familiar with the technology.